Rivaroxaban or Aspirin for Biological Aortic Prosthesis

Clinical trial NCT02974920 · UNKNOWN

Trial details

NCT number: NCT02974920
Sponsor: Christian Torp-Pedersen
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Aortic Stenosis Aortic Regurgitation Thrombosis

Start date: 2017-01-01
Primary completion: 2022-11-01
Enrollment: 1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.